N-glycosylation of Colorectal Cancer Tissues

Colorectal cancer is the third most common cancer worldwide with an annual incidence of ∼1 million cases and an annual mortality rate of ∼655,000 individuals. There is an urgent need for identifying novel targets to develop more sensitive, reliable, and specific tests for early stage detection of colon cancer. Post-translational modifications are known to play an important role in cancer progression and immune surveillance of tumors. In the present study, we compared the N-glycan profiles from 13 colorectal cancer tumor tissues and corresponding control colon tissues. The N-glycans were enzymatically released, purified, and labeled with 2-aminobenzoic acid. Aliquots were profiled by hydrophilic interaction liquid chromatography (HILIC-HPLC) with fluorescence detection and by negative mode MALDI-TOF-MS. Using partial least squares discriminant analysis to investigate the N-glycosylation changes in colorectal cancer, an excellent separation and prediction ability were observed for both HILIC-HPLC and MALDI-TOF-MS data. For structure elucidation, information from positive mode ESI-ion trap-MS/MS and negative mode MALDI-TOF/TOF-MS was combined. Among the features with a high separation power, structures containing a bisecting GlcNAc were found to be decreased in the tumor, whereas sulfated glycans, paucimannosidic glycans, and glycans containing a sialylated Lewis type epitope were shown to be increased in tumor tissues. In addition, core-fucosylated high mannose N-glycans were detected in tumor samples. In conclusion, the combination of HILIC and MALDI-TOF-MS profiling of N-glycans with multivariate statistical analysis demonstrated its potential for identifying N-glycosylation changes in colorectal cancer tissues and provided new leads that might be used as candidate biomarkers.

[1]  Kiyotoshi Inoue,et al.  High Serum Concentrations of Sialyl Lewisx Predict Multilevel N2 Disease in Non–Small-Cell Lung Cancer , 2006, Annals of Surgical Oncology.

[2]  M. Glick,et al.  Purification and characterization of GDP-L-fucose-N-acetyl beta-D-glucosaminide alpha 1----6fucosyltransferase from cultured human skin fibroblasts. Requirement of a specific biantennary oligosaccharide as substrate. , 1991, The Journal of biological chemistry.

[3]  André M Deelder,et al.  Mass spectrometry of proton adducts of fucosylated N-glycans: fucose transfer between antennae gives rise to misleading fragments. , 2006, Rapid communications in mass spectrometry : RCM.

[4]  X. Qin,et al.  Glycan changes: cancer metastasis and anti-cancer vaccines , 2010, Journal of Biosciences.

[5]  C. Batt,et al.  Glycosylation Profiles of the Human Colorectal Cancer A33 Antigen Naturally Expressed in the Human Colorectal Cancer Cell Line SW1222 and Expressed as Recombinant Protein in Different Insect Cell Lines , 2004, Biotechnology progress.

[6]  A. Elbein,et al.  The effect of glycoprotein-processing inhibitors on fucosylation of glycoproteins. , 1985, The Journal of biological chemistry.

[7]  H. Slocum,et al.  Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of α1,2-fucosyltransferase activities , 2007, Journal of Cancer Research and Clinical Oncology.

[8]  J. Michalski,et al.  Glycoproteomics and glycomics investigation of membrane N‐glycosylproteins from human colon carcinoma cells , 2008, Proteomics.

[9]  R. Dwek,et al.  Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. , 2006, Glycobiology.

[10]  R. Kiss,et al.  Quantitative glycohistochemistry defines new prognostic markers for cancers of the oral cavity , 1998, Cancer.

[11]  T. Niki,et al.  Determination of Carbohydrate‐Binding Preferences of Human Galectins with Carbohydrate Microarrays , 2010, Chembiochem : a European journal of chemical biology.

[12]  Masaki Kitajima,et al.  Expression of Sialyl Lewisa as a new prognostic factor for patients with advanced colorectal carcinoma , 1995 .

[13]  Yanlei Ma,et al.  Proteomics Identification of Desmin as a Potential Oncofetal Diagnostic and Prognostic Biomarker in Colorectal Cancer* , 2009, Molecular & Cellular Proteomics.

[14]  R. Kiss,et al.  Upregulation of galectins‐1 and ‐3 in human colon cancer and their role in regulating cell migration , 2003, International journal of cancer.

[15]  G. Fleuren,et al.  HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression , 2007, BMC Cancer.

[16]  P. Stanley,et al.  Tumor and Stem Cell Biology Cancer Research The Bisecting GlcNAc on N-Glycans Inhibits Growth Factor Signaling and Retards Mammary Tumor Progression , 2010 .

[17]  J A Swets,et al.  Measuring the accuracy of diagnostic systems. , 1988, Science.

[18]  J. Gu,et al.  A mutual regulation between cell-cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions. , 2009, Journal of proteome research.

[19]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[20]  H. Kuwano,et al.  α1‐Acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis , 2004, Cancer.

[21]  M. Kitajima,et al.  Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma. , 1995, Cancer.

[22]  P. Rudd,et al.  Evaluation of the serum N‐linked glycome for the diagnosis of cancer and chronic inflammation , 2008, Proteomics.

[23]  G. Turner.  N-glycosylation of serum proteins in disease and its investigation using lectins. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[24]  Pauline M Rudd,et al.  Novel glycan biomarkers for the detection of lung cancer. , 2011, Journal of proteome research.

[25]  Scott R. Kronewitter,et al.  Glycomics and disease markers. , 2009, Current opinion in chemical biology.

[26]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[27]  T Nilsson,et al.  Mapping the distribution of Golgi enzymes involved in the construction of complex oligosaccharides. , 1995, Journal of cell science.

[28]  M. Dyer,et al.  The search for the retinoblastoma cell of origin , 2005, Nature Reviews Cancer.

[29]  T. Hall,et al.  Enzyme activity in invasive tumors of human breast and colon. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[30]  I. Brockhausen,et al.  Role and Metabolism of Glycoconjugate Sulfation , 1997 .

[31]  M. Mori,et al.  Immunohistochemical expression of carbohydrate antigen 19-9 in colorectal carcinoma. , 1994, The American journal of gastroenterology.

[32]  A. Deelder,et al.  Repeats of LacdiNAc and fucosylated LacdiNAc on N‐glycans of the human parasite Schistosoma mansoni , 2006, The FEBS journal.

[33]  P. Rudd,et al.  Altered Glycosylation in Tumours Focused to Cancer Diagnosis , 2009, Disease markers.

[34]  D. Ota,et al.  Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastases. , 1989, Cancer research.

[35]  E. Steenvoorden,et al.  2‐Picoline‐borane: A non‐toxic reducing agent for oligosaccharide labeling by reductive amination , 2010, Proteomics.

[36]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[37]  R. Caprioli,et al.  Proteome analysis of human colon cancer by two‐dimensional difference gel electrophoresis and mass spectrometry , 2004, Proteomics.

[38]  André M Deelder,et al.  Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides. , 2011, Analytical chemistry.

[39]  J. Terdiman.  Colonoscopy is superior to flexible sigmoidoscopy for colorectal cancer screening: now beyond a reasonable doubt? , 2005, Gastroenterology.

[40]  N. Taniguchi,et al.  Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Miyauchi,et al.  Expression of alpha1,6-fucosyltransferase (FUT8) in papillary carcinoma of the thyroid: its linkage to biological aggressiveness and anaplastic transformation. , 2003, Cancer letters.

[42]  J. Bergquist,et al.  High-mannose-type oligosaccharides from human placental arylsulfatase A are core fucosylated as confirmed by MALDI MS. , 2000, Glycobiology.

[43]  T Irimura,et al.  Differential production of high molecular weight sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma, and metastases. , 1987, Cancer research.

[44]  Yukari Nakajima,et al.  Alteration of N‐glycosylation in the kidney in a mouse model of systemic lupus erythematosus: relative quantification of N‐glycans using an isotope‐tagging method , 2009, Immunology.

[45]  Yue Fan,et al.  Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. , 2011, Glycobiology.

[46]  S. Hakomori,et al.  Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. , 2001, Advances in experimental medicine and biology.

[47]  K. Zwierz,et al.  N-acetyl-beta-D-hexosaminidase and its isoenzymes A and B in blood serum and urine, as a potential colon cancer markers. , 2009, Hepato-gastroenterology.

[48]  B. Ross,et al.  Molecular Imaging of N-linked Glycosylation Suggests Glycan Biosynthesis Is a Novel Target for Cancer Therapy , 2010, Clinical Cancer Research.

[49]  J. Ko,et al.  Comparative quantitation of aberrant glycoforms by lectin-based glycoprotein enrichment coupled with multiple-reaction monitoring mass spectrometry. , 2010, Analytical chemistry.

[50]  J. Alhadeff,et al.  β-Hexosaminidase From Colon and Sera of Dukes-Classified Colorectal Cancer Patients: Activity Levels, Isozyme Patterns, and Kinetic Properties , 1986 .

[51]  M. Nakazato.  Immunoloric Fecal Occult Blood Test for Colorectal Cancer Screening , 2006 .

[52]  Y. Ikeda,et al.  Immunohistochemical expression of carbohydrate antigen 19-9 in gastric carcinoma. , 1991, The American journal of gastroenterology.

[53]  K. Wakasa,et al.  Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. , 2007, Lung cancer.

[54]  Anna Laskowska,et al.  Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells. , 2002, Acta biochimica Polonica.

[55]  M. Farquhar,et al.  Cell type-dependent variations in the subcellular distribution of alpha- mannosidase I and II , 1993, The Journal of cell biology.

[56]  M. Páez de la Cadena,et al.  Alterations of glycosidases in human colonic adenocarcinoma. , 1997, Clinical biochemistry.

[57]  H. Schachter.  Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. , 1986, Advances in experimental medicine and biology.

[58]  D. Stuart,et al.  Disruption of α‐mannosidase processing induces non‐canonical hybrid‐type glycosylation , 2007 .

[59]  Kazuhiko Fujita,et al.  Immunologic Fecal Occult Blood Test for Colorectal Cancer Screening , 2006 .

[60]  A. Varki,et al.  Glycosylation Changes in Cancer , 2009 .

[61]  Scott R. Kronewitter,et al.  High-Mannose Glycans are Elevated during Breast Cancer Progression* , 2010, Molecular & Cellular Proteomics.

[62]  L. Eriksson.  Multi- and megavariate data analysis , 2006 .

[63]  S. Hakomori,et al.  Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. , 1989, Advances in cancer research.

[64]  K. Zwierz,et al.  Lysosomal exoglycosidases in serum and urine of patients with colon adenocarcinoma. , 2008, Hepato-gastroenterology.

[65]  Tasneem H. Patwa,et al.  Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. , 2008, Journal of proteome research.

[66]  N. Coleman,et al.  Colorectal cancer screening: prospects for molecular stool analysis , 2005, Nature Reviews Cancer.

[67]  Pauline M Rudd,et al.  A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. , 2008, Glycobiology.

[68]  Y. Mechref,et al.  Alterations in the serum glycome due to metastatic prostate cancer. , 2007, Journal of proteome research.

[69]  Y. Matsuzawa,et al.  Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization. , 1996, Cancer research.

[70]  J. Wieruszeski,et al.  Sulfated Lewis X Determinants as a Major Structural Motif in Glycans from LS174T-HM7 Human Colon Carcinoma Mucin* , 1997, The Journal of Biological Chemistry.

[71]  B. Levin,et al.  Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers , 2003, CA: a cancer journal for clinicians.

[72]  J. Magner,et al.  Subcellular localization of fucose incorporation into mouse thyrotropin and free alpha-subunits: studies employing subcellular fractionation and inhibitors of the intracellular translocation of proteins. , 1986, Endocrinology.

[73]  K. Wakasa,et al.  Serum Sialyl Lewisx and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer , 2007 .

[74]  K. Zwierz,et al.  Isoenzymes A and B of N-acetyl-beta-D-hexosaminidase in serum and urine of patients with pancreatic cancer. , 2008, Hepato-gastroenterology.

[75]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[76]  S. Neelamegham,et al.  The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. , 2006, Carbohydrate research.

[77]  A. Nanashima,et al.  Circulating sialyl Lewisx, sialyl Lewisa, and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels , 2001, Journal of Gastroenterology.